Newleos Therapeutics, Inc.
Clinical trials sponsored by Newleos Therapeutics, Inc., explained in plain language.
-
New pill aims to curb alcohol cravings in early trial
Disease control Recruiting nowThis early-stage trial tests a new drug called NTX-2001 in 50 adults with alcohol use disorder. Participants take the drug or a placebo daily for two weeks. Researchers will measure how much alcohol they drink and check for side effects. The goal is to see if this drug can safely…
Phase: PHASE1 • Sponsor: Newleos Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Could a brain chemical blocker ease social anxiety? new trial launches
Symptom relief Recruiting nowThis Phase 2 trial tests whether a new drug called NTX-1472 can safely reduce symptoms of social anxiety disorder. About 100 adults will take either the drug or a placebo daily for 8 weeks. Researchers will measure changes in anxiety and avoidance using a standard scale, and trac…
Phase: PHASE2 • Sponsor: Newleos Therapeutics, Inc. • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC